# VEGF Imaging in Renal Cell Carcinoma

> **NCT00831857** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 26 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **OTHER:** 89Zr-Bevacizumab PET-scan

## Key facts

- **NCT ID:** NCT00831857
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831857, "VEGF Imaging in Renal Cell Carcinoma". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00831857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*